跳至主要内容
临床试验/EUCTR2014-000246-30-DE
EUCTR2014-000246-30-DE进行中(未招募)1 期

Intravenous ferric carboxymaltose vs. oral iron substitution in patients with metastatic colorectal cancer (CRC) and iron deficiency anemia: a randomized multicenter treatment optimization study. - FERINJECT

IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest gGmbH0 个研究点目标入组 64 人开始时间: 2014年6月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Metastatic or inoperable colorectal carcinoma. No curative therapy available.
  • 2. Current palliative chemotherapy. Patients under conversion therapy must not be enrolled to this study.
  • 3. Iron deficiency anemia: hemoglobin = 10.5 g/dl and transferrin saturation < 20 % and/or serum ferritin < 20 ng/ml
  • 4. Male and female patients aged = 18 years; maturity
  • 5. ECOG = 2
  • 6. Written informed consent
  • 7. Life expectancy > 6 months
  • 8. Body weight = 40 kg
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 64
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 64

排除标准

  • 1. Oral or intravenous iron substitution within the last 4 weeks
  • 2. Age < 18 years or body weight < 40 kg
  • 3. Absorption dysfunction due to short bowel syndrome or after gastric resection
  • 4. Therapy with recombinant erythropoietin within the last 4 weeks
  • 5. Chronic diarrhea
  • 6. Chronic inflammatory bowel disease
  • 7. Ferritin > 800 mg/dl at baseline
  • 8. Hypersensitivity or contraindication to ferric carboxymaltose or iron (II) glycine sulphate complex
  • 9. Known vitamin B12 or folic acid anemia
  • 10. Necessary total parenteral nutrition
  • 11. Participation in another interventional study
  • 12. Pregnancy or lactation

研究者

发起方
IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest gGmbH

相似试验

Comparison of two ways of iron intake for patients... | 临床试验